NCT05237947 2026-03-19
PRISMA
National Cancer Institute (NCI)
Phase 4 Active not recruiting
Clinical Trials
12 trialsNCT06658405 2026-03-18
HPV2
Centre Oscar Lambret
Phase 2 Recruiting
NCT03036930 2026-03-11
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT03284866 2026-01-28
COVENANT
AIDS Malignancy Consortium
Phase 3 Completed
NCT04206813 2026-01-27
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Boston Medical Center
Phase 4 Active not recruiting
NCT03023631 2025-11-18
Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
M.D. Anderson Cancer Center
Phase 4 Active not recruiting
NCT05087849 2025-10-02
Intralesional HPV Vaccine for Condylomata
University of California, San Francisco
Phase 1/2 Completed
NCT05985681 2025-09-29
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT03180034 2025-09-04
ESCUDDO
National Cancer Institute (NCI)
Phase 4 Active not recruiting
NCT04982614 2025-08-24
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
Columbia University
Phase 4 Completed
NCT06793410 2025-06-05
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Vastra Gotaland Region
Phase 2 Recruiting
NCT05266898 2025-04-18
AGO-Gard
Louisiana State University Health Sciences Center in New Orleans
Phase 4 Recruiting